Bibliografische Daten

Dokument WO002013160365A1 (Seiten: 37)

Bibliografische Daten Dokument WO002013160365A1 (Seiten: 37)
INID Kriterium Feld Inhalt
54 Titel TI [EN] STEREOSELECTIVE HYDROXYLATION OF BENZENES
[FR] HYDROXYLATION STÉRÉOSÉLECTIVE DES BENZÈNES
71/73 Anmelder/Inhaber PA DSM IP ASSETS BV, NL ; RWTH AACHEN, DE
72 Erfinder IN BONRATH WERNER, CH ; DENNIG ALEXANDER, DE ; MARIENHAGEN JAN, DE ; RUFF ANNA JOELLE, BE ; SCHUERMANN MARTIN, NL ; SCHWANENBERG ULRICH, BE
22/96 Anmeldedatum AD 24.04.2013
21 Anmeldenummer AN 2013058525
Anmeldeland AC EP
Veröffentlichungsdatum PUB 31.10.2013
33
31
32
Priorität PRC
PRN
PRD
EP
12165386
20120424
51 IPC-Hauptklasse ICM C12P 33/06 (2006.01)
51 IPC-Nebenklasse ICS C12N 9/00 (2006.01)
C12N 9/02 (2006.01)
IPC-Zusatzklasse ICA
IPC-Indexklasse ICI
Gemeinsame Patentklassifikation CPC C12N 9/0071
C12P 17/06
C12P 7/22
C12Y 114/14001
MCD-Hauptklasse MCM C12P 33/06 (2006.01)
MCD-Nebenklasse MCS C12N 9/00 (2006.01)
C12N 9/02 (2006.01)
MCD-Zusatzklasse MCA
57 Zusammenfassung AB [EN] The present invention relates to novel cytochrome P450 monooxygenase with modified (higher) substrate selectivity and/or (re)activity towards aromatic hydroxylation of benzenes. In particular, the invention provides nucleic acid sequences coding for the novel enzymes, expression constructs and vectors comprising these sequences, transformed microorganisms expressing these novel enzymes, and processes for the stereoselective hydroxylation of substituted benzenes useful as building blocks in vitamin E synthesis.
[FR] Cette invention concerne une nouvelle cytochrome P450 monooxygénase ayant une sélectivité de substrat et/ou une (ré)activité vis-à-vis de l'hydroxylation des benzènes modifiées (supérieures). En particulier, l'invention concerne des séquences d'acides nucléiques codant pour les nouvelles enzymes, des produits et recombinaison et des vecteurs d'expression les contenant, des micro-organismes transformés exprimant ces nouvelles enzymes, et des procédés d'hydroxylation stéréosélective de benzènes substitués utiles à titre d'éléments structuraux dans la synthèse de la vitamine E.
56 Entgegengehaltene Patentdokumente/Zitate,
in Recherche ermittelt
CT WO002009047498A2
WO002010064764A1
56 Entgegengehaltene Patentdokumente/Zitate,
vom Anmelder genannt
CT
56 Entgegengehaltene Nichtpatentliteratur/Zitate,
in Recherche ermittelt
CTNP CARMICHAEL A B ET AL: "Protein engineering of Bacillus megaterium CYP102.The oxidation of polycyclic aromatic hydrocarbons", EUROPEAN JOURNAL OF BIOCHEMISTRY, BLACKWELL PUBLISHING, BERLIN, DE, vol. 268, no. 10, 1 May 2001 (2001-05-01), pages 3117 - 3125, XP002449232, ISSN: 0014-2956, DOI: 10.1046/J.1432-1327.2001.02212.X 7;
CHRISTOPHER J. C. WHITEHOUSE ET AL: "Dearomatisation of o-Xylene by P450BM3 (CYP102A1)", CHEMISTRY - A EUROPEAN JOURNAL, vol. 17, no. 24, 6 June 2011 (2011-06-06), pages 6862 - 6868, XP055041233, ISSN: 0947-6539, DOI: 10.1002/chem.201002465 7;
MUNRO A W ET AL: "P450 BM3: the very model of a modern flavocytochrome", TRENDS IN BIOCHEMICAL SCIENCES, ELSEVIER, HAYWARDS, GB, vol. 27, no. 5, 1 May 2002 (2002-05-01), pages 250 - 257, XP004366127, ISSN: 0968-0004, DOI: 10.1016/S0968-0004(02)02086-8 7;
OLIVER C F ET AL: "Engineering the substrate specificity of Bacillus megaterium cytochrome P-450 BM3: Hydroxylation of alkyl trimethylammonium compounds", BIOCHEMICAL JOURNAL, THE BIOCHEMICAL SOCIETY, LONDON, GB, vol. 327, no. 2, 1 January 1997 (1997-01-01), pages 537 - 544, XP002156031, ISSN: 0264-6021 7;
S. A. BARDOWELL ET AL: "Common Variants of Cytochrome P450 4F2 Exhibit Altered Vitamin E- -Hydroxylase Specific Activity", THE JOURNAL OF NUTRITION, vol. 140, no. 11, 1 November 2010 (2010-11-01), pages 1901 - 1906, XP055041219, ISSN: 0022-3166, DOI: 10.3945/jn.110.128579 7
56 Entgegengehaltene Nichtpatentliteratur/Zitate,
vom Anmelder genannt
CTNP "Ullmann's Encyclopedia of Industrial Chemistry, 6th, completely revised edition,", vol. 38, 2002, WILEY-VCH 1;
AUSUBEL, F. M. ET AL.: "Current Protocols in Molecular Biology", 1987, GREENE PUBLISHING ASSOC. AND WILEY INTERSCIENCE 1;
BERNHARDT, J. BIOTECHNOL., vol. 124, 2006, pages 128 - 145 1;
BLANUSA ET AL., ANAL. BIOCHEM, vol. 406, 2011, pages 141 - 146 1;
EUR. J. BIOCHEM., vol. 123, 1982, pages 473 - 475 1;
FIRTH ET AL., NUCLEIC ACIDS RES., vol. 36, 2008, pages W281 - 285 1;
HANAHAN ET AL., METHODS IN ENZYMOLOGY, vol. 204, 1991, pages 63 - 113 1;
HARLOW, E.; LANE, D.: "Antibodies: A Laboratory Manual", 1988, COLD SPRING HARBOR (N.Y.) PRESS 1;
INOUE ET AL., GENE, vol. 96, 1990, pages 23 - 28 1;
LYER ET AL., BIOCHEMISTRY, vol. 36, 1997, pages 7136 - 7143 1;
MORAWSKI ET AL., PROTEIN ENG., vol. 13, 2000, pages 377 - 384 1;
NAZOR ET AL., PROTEIN ENG., DES. SEL., vol. 21, 2008, pages 29 - 35 1;
OMURA; SATO, J. BIOL. CHEM., vol. 239, 1964, pages 2379 - 2385 1;
SCHWANEBERG ET AL., J. CHROMATOGR., A, vol. 848, 1999, pages 149 - 159 1;
T. J. SILHAVY; M. L. BERMAN; L. W. ENQUIST: "Experiments with Gene Fusions", 1984, COLD SPRING HARBOR LABORATORY 1;
T. MANIATIS; E. F. FRITSCH; J. SAMBROOK: "Molecular Cloning: A Laboratory Manual", 1989, COLD SPRING HARBOR LABORATORY 1;
WHITEHOUSE ET AL., CHEMBIOCHEM, vol. 11, 2010, pages 2549 - 2556 1;
WONG ET AL., J. BIOMOL. SCREENING, vol. 10, 2005, pages 246 - 252 1
Zitierende Dokumente Dokumente ermitteln
Sequenzprotokoll
Prüfstoff-IPC ICP C12N 9/00
C12N 9/02
C12P 33/06